• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [24038 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2013     Scottish Health Technologies Group (SHTG) Are silver dressings clinically effective and cost effective for the healing of infected wounds and the prevention of wound infection relative to other types of dressing?
2013     Agency for Healthcare Research and Quality (AHRQ) Interventions for feeding and nutrition in cerebral palsy
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Long-acting beta-agonists and inhaled corticosteroids for treatment of chronic obstructive pulmonary disease: a review of the clinical efficacy and cost-effectiveness
2013     National Institute for Health and Care Excellence (NICE) Percutaneous closure of patent foramen ovale to prevent recurrent cerebral embolic events. NICE interventional procedures guidance 472
2013     The Netherlands Organisation for Health Research and Development (ZonMw) [Accuracy and cost-effectiveness of two clinical decision rules for the diagnosis of deep vein thrombosis and pulmonary embolism in residents of nursing homes and homes for the elderly]
2013     Scottish Health Technologies Group (SHTG) Does the addition of positron emission tomography/computed tomography (PET/CT) to the routine investigation and assessment of patients with sarcoidosis yield clinical and economic benefits?
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Non-pharmacological therapies for the treatment of insomnia in adults: clinical evidence and guidelines
2013     Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: mammography in two directions as standard
2013     National Institute for Health and Care Excellence (NICE) Uterine artery embolisation for treating adenomyosis. NICE interventional procedures guidance 473
2013     Scottish Health Technologies Group (SHTG) What is the clinical and cost effectiveness of dynamic elastomeric fabric orthoses (DEFOs) for cerebral palsy?
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Sleep medications for adults diagnosed with insomnia: clinical evidence and harms
2013     Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: calcium score and the risk of cardiovascular disease
2013     National Institute for Health and Care Excellence (NICE) Negative pressure wound therapy for the open abdomen. NICE interventional procedures guidance 467
2013     Scottish Health Technologies Group (SHTG) Can wrist splints or steroid injections reduce the need for decompression surgery in carpal tunnel syndrome?
2013     Andalusian Health Technology Assessment Area (AETSA) [Biological therapies in the treatment of ankylosing spondylitis: a comparison of efficacy and safety between different biological inhibitors of tumour necrosis factor-alpha]
2013     Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: national population screening programme for bowel cancer
2013     National Institute for Health and Care Excellence (NICE) Phrenic nerve transfer in brachial plexus injury. NICE interventional procedures guidance 468
2013     Scottish Health Technologies Group (SHTG) What is the sensitivity and specificity of PET/CT compared with other diagnostic imaging modalities in determining the cause of pyrexia of unknown origin (PUO)? What is the clinical and cost effectiveness of PET/CT as a first-line investigation in patients with PUO?
2013     Andalusian Health Technology Assessment Area (AETSA) [Monoclonal antibodies associated with chemotherapy as first line therapy in metastatic colorectal cancer: relative efficacy, safety and efficiency]
2013     Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: Continuing a population screening trial
2013     National Institute for Health and Care Excellence (NICE) Implantation of a duodenal–jejunal bypass sleeve for managing obesity. NICE interventional procedures guidance 471
2013     Health Council of the Netherlands Gezondheidsraad (GR) The individual, collective and public importance of vaccination
2013     National Institute for Health and Care Excellence (NICE) Photochemical corneal collagen cross-linkage using riboflavin and ultraviolet A for keratoconus and keratectasia. NICE interventional procedures guidance 466
2013     Scottish Health Technologies Group (SHTG) What is the clinical effectiveness, cost effectiveness and implications for safety of assessing anti-tumour necrosis factor (TNF)α drug levels and antibodies in children with moderate to severe inflammatory bowel disease compared with existing clinical strategies in use in NHS Scotland?
2013     Andalusian Health Technology Assessment Area (AETSA) [Efficacy and cost-effectiveness of molecular techniques in the intraoperative assessment of the sentinel lymph node]
2013     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination of infants against pneumococcal infections (3)
2013     National Institute for Health and Care Excellence (NICE) Endoscopic radiofrequency ablation for gastro-oesophageal reflux disease. NICE interventional procedures guidance 461
2013     Scottish Health Technologies Group (SHTG) PET/CT for the inversitgation of paraneoplastic syndromes (PNS)
2013     Andalusian Health Technology Assessment Area (AETSA) [New treatments in organ-confined cancer vs. prostatectomy. Systematic review. Ablation with cryotherapy, HIFU and laser-therapy]
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Summary of the exploration of the scientific literature on the effects of prostate cancer screening decision aids for the expert panel of the Collège des médecins du Québec]
2013     Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: bowel cancer screening by pill camera
2013     National Institute for Health and Care Excellence (NICE) Translaryngeal tracheostomy. NICE interventional procedures guidance 462
2013     NIHR Health Technology Assessment programme Echocardiography in newly diagnosed atrial fibrillation patients: a systematic review and economic evaluation
2013     Scottish Health Technologies Group (SHTG) Is patient self-monitoring (including self-testing and self-management) of oral anticoagulation therapy safe, efficacious, and cost effective? (update of EN 27)
2013     Andalusian Health Technology Assessment Area (AETSA) [Efficacy, safety and efficiency of transcutaneous nerve stimulation for the treatment of chronic musculoskeletal pain]
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Traumatic and non-traumatic spinal cord injury: a comparative analysis of the characteristics and organization of rehabilitation care and services in Québec]
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Transcatheter aortic valve replacement in severe aortic stenosis: a review of comparative durability and clinical effectiveness beyond 12 months
2013     Health Council of the Netherlands Gezondheidsraad (GR) NIPT: dynamics and ethics of prenatal screening
2013     National Institute for Health and Care Excellence (NICE) Insertion of customised exposed titanium implants, without soft tissue cover, for complex orofacial reconstruction. NICE interventional procedures guidance 457
2013     NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of acupressure for the control and management of chemotherapy-related acute and delayed nausea: Assessment of Nausea in Chemotherapy Research (ANCHoR), a randomised controlled trial
2013     Andalusian Health Technology Assessment Area (AETSA) [Active immunotherapy for breast cancer]
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of prolotherapy in the treatment of chronic musculoskeletal conditions]
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Screening for sexually transmitted infections: a review of guidelines
2013     Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: noninvasive prenatal test for increased risk of trisomy
2013     HTA Unit, University of Calgary Use of Oncotype DX for guiding adjuvant chemotherapy decisions in early stage invasive breast cancer patients in Alberta
2013     National Institute for Health and Care Excellence (NICE) Selective internal radiation therapy for primary hepatocellular carcinoma. NICE interventional procedures guidance 460
2013     Scottish Health Technologies Group (SHTG) What is the evidence for the clinical and cost effectiveness of major trauma centres as the core component of a trauma service, compared with standard care for adults with major trauma?
2013     Agency for Healthcare Research and Quality (AHRQ) Update on emerging genetic tests currently available for clinical use in common cancers
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Notice on the reimbursement of proton pump inhibitors]
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Brentuximab for refractory CD30+ Hodgkin's lymphoma: clinical and cost-effectiveness
2013     National Institute for Health and Care Excellence (NICE) Insertion of customised titanium implants, with soft tissue cover, for orofacial reconstruction. NICE interventional procedures guidance 449
2013     Scottish Health Technologies Group (SHTG) Is cone beam computed tomography (CBCT) clinically effective, cost-effective and safe compared with standard extraoral and intraoral radiography in the diagnosis of hard tissue pathology in routine dental practice?
2013     Agency for Healthcare Research and Quality (AHRQ) Making health care safer II: an updated critical analysis of the evidence for patient safety practices
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Treatment and follow-up of children with sickle cell disease (SCD)]
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Administration of anesthesia by anesthesiologists versus non-physicians for patients undergoing cataract surgery: clinical effectiveness, cost-effectiveness, and guidelines
2013     National Institute for Health and Care Excellence (NICE) Occipital nerve stimulation for intractable chronic migraine. NICE interventional procedures guidance 452
2013     The Netherlands Organisation for Health Research and Development (ZonMw) [Effects and costs of a national continuous improvement programme on cardiovascular diseases in primary care]
2013     Agency for Healthcare Research and Quality (AHRQ) Screening for suicide risk in primary care: a systematic evidence review for the U.S. Preventive Services Task Force.
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Systemic hyperbaric oxygen therapy for the treatment of idiopathic sudden sensorineural hearing loss]
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Standing tables for adults with cerebral palsy: a review of the clinical evidence
2013     National Institute for Health and Care Excellence (NICE) Corneal inlay implantation for correction of presbyopia. NICE interventional procedures guidance 455
2013     NIHR Health Technology Assessment programme MAGNEsium Trial In Children (MAGNETIC): a randomised, placebo controlled trial and economic evaluation of nebulised magnesium sulphate in acute severe asthma in children
2013     Agency for Healthcare Research and Quality (AHRQ) Screening for oral cancer: a targeted evidence update for the U.S. Preventive Services Task Force
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Overview of dabigatran usage among people insured by the public prescription drug insurance plan]
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Tools and devices for the management of dementia in older adults: review of evidence-based guidelines
2013     Malaysian Health Technology Assessment (MaHTAS) Intraocular lens (IOL) implantation and opacification – an update
2013     National Institute for Health and Care Excellence (NICE) Electrochemotherapy for metastases in the skin from tumours of non-skin origin and melanoma. NICE interventional procedures guidance 446
2013     Agency for Healthcare Research and Quality (AHRQ) Assessment and management of chronic cough
2013     Agency for Healthcare Research and Quality (AHRQ) The ankle brachial index for peripheral artery disease screening and cardiovascular disease prediction in asymptomatic adults: a systematic evidence review for the U.S. Preventive Services Task Force
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Overview of the drugs used by children and adolescents diagnosed with autism spectrum disorder who are covered by the Public Prescription Drug Insurance Plan]
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Beta human chorionic gonadotropin test for detection of early pregnancy: clinical effectiveness, cost-effectiveness, and guidelines
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Falls in patients living in health care facilities (short- and long-term care)]
2013     Institute of Health Economics (IHE) Islet transplantation for the treatment of type 1 diabetes [update]
2013     Malaysian Health Technology Assessment (MaHTAS) Collagen for anti aging treatment, enhance cell regeneration and boosting the immune system
2013     National Institute for Health and Care Excellence (NICE) Insertion of endobronchial valves for persistent air leaks. NICE interventional procedures guidance 448
2013     NIHR Health Technology Assessment programme Randomised Assessment of Treatment using Panel Assay of Cardiac markers - Contemporary Biomarker Evaluation (RATPAC CBE)
2013     Agency for Healthcare Research and Quality (AHRQ) Outpatient case management for adults with medical illness and complex care needs
2013     Scottish Health Technologies Group (SHTG) What approaches have been taken and efforts made to ensure public involvement in decision making relating to potential disinvestment in healthcare interventions and technologies?
2013     Agency for Healthcare Research and Quality (AHRQ) Screening for hypertension in children and adolescents to prevent cardiovascular disease: systematic review for the U.S. Preventive Services Task Force.
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Use of intrathecal pumps for the treatment of chronic non-cancer pain]
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Interventions used to determine the appropriate patient populations for cataract surgery: a review of the clinical evidence and guidelines
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Self-monitoring of blood glucose in adult patients with Type 2 Diabetes not using insulin]
2013     National Institute for Health and Care Excellence (NICE) Percutaneous electrical nerve stimulation for refractory neuropathic pain. NICE interventional procedures guidance 450
2013     NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of acupressure for the control and management of chemotherapy-related acute and delayed nausea: Assessment of Nausea in Chemotherapy Research (ANCHoR), a randomised controlled trial
2013     Agency for Healthcare Research and Quality (AHRQ) Child and adolescent exposure to trauma: comparative effectiveness of interventions addressing trauma other than maltreatment or family violence
2013     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry: Maple Syrup Urine Disease, Homocystinuria, Glutaric Aciduria Type I, Isovaleric Acidaemia, Long-chain 3-Hydroxyacyl CoA Dehydrogenase Deficiency]
2013     Agency for Healthcare Research and Quality (AHRQ) Behavioral interventions and counseling to prevent child abuse and neglect: systematic review to update the U.S. Preventive Services Task Force Recommendation.
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Sublingual immunotherapy for respiratory allergies]
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Antimicrobial drapes for the reduction of surgical site infection: clinical effectiveness
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Efficiency of short-term social and psychological therapies: Systematic review]
2013     National Institute for Health and Care Excellence (NICE) Peripheral nerve-field stimulation for chronic low back pain. NICE interventional procedures guidance 451
2013     Agency for Healthcare Research and Quality (AHRQ) Intravascular diagnostic procedures and imaging techniques versus angiography alone in coronary artery stenting: comparative effectiveness review
2013     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Development of quality indicators for laser treatment for benign prostatic hyperplasia. Expert consensus]
2013     Institut national d'excellence en sante et en services sociaux (INESSS) [Digital screening mammography. Critical analysis of the article by Chiarelli (2013) and literature review]
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Compression bandage measurement devices for the use in adult patients with chronic venous insufficiency: clinical effectiveness
2013     Agenzia nazionale per i servizi sanitari regionali (Agenas) Implantable devices for the closure of patent foramen ovale (PFO) in adults. Rapid HTA report
2013     Malaysian Health Technology Assessment (MaHTAS) Negative pressure wound therapy (Renasys Go Console Package)
2013     National Institute for Health and Care Excellence (NICE) Irreversible electroporation for treating primary lung cancer and metastases in the lung. NICE interventional procedures guidance 441
2013     The Netherlands Organisation for Health Research and Development (ZonMw) [Laparoscopic ileocolic resection versus infliximab treatment of recurrent distal ileitis in Crohn's disease: a randomized multicenter trial]
2013     NIHR Health Technology Assessment programme Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation